A fully closed-loop artificial pancreas system improved glucose control and reduced hypoglycemia compared with standard insulin therapy in adult outpatients with type 2 diabetes requiring dialysis, a small...

The Food and Drug Administration has approved exenatide extended release (Bydureon/Bydureon BCise, AstraZeneca) for use in children with type 2 diabetes down to 10 years of age, the agency announced July...

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. California is expanding its coronavirus vaccine program to include people aged 16-64...